Lp(a) is one of the most clinically meaningful — and most under-tested — cardiovascular risk factors in routine practice. Inaccurate assays, inconsistent reporting standards and disparities in testing across patient populations leave many at-risk patients undiagnosed and undertreated. This on-demand…
On Demand
Presented by:
Presenters
Howard S. Weintraub, MD, FACC, FAHA, FASPC
Clinical Professor of Medicine, NYU Grossman School of Medicine Clinical Director, NYU Center for the Prevention of Cardiovascular Disease
Leslie J. Donato, Ph.D., D(ABCC)
Co-Director Clinical Specialty Laboratory Co-Director Hospital Clinical Laboratory and Point of Care Associate Professor, Laboratory Medicine and Pathology Department of Laboratory Medicine and Pathology at Mayo Clinic
